These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
634 related articles for article (PubMed ID: 17304245)
1. Strategies for silencing human disease using RNA interference. Kim DH; Rossi JJ Nat Rev Genet; 2007 Mar; 8(3):173-84. PubMed ID: 17304245 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies. Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620 [TBL] [Abstract][Full Text] [Related]
5. An update on RNA interference-mediated gene silencing in cancer therapy. Ren YJ; Zhang Y Expert Opin Biol Ther; 2014 Nov; 14(11):1581-92. PubMed ID: 25010067 [TBL] [Abstract][Full Text] [Related]
6. RNAi and miRNA in viral infections and cancers. Mollaie HR; Monavari SH; Arabzadeh SA; Shamsi-Shahrabadi M; Fazlalipour M; Afshar RM Asian Pac J Cancer Prev; 2013; 14(12):7045-56. PubMed ID: 24460249 [TBL] [Abstract][Full Text] [Related]
7. Using RNAi in the clinic. Dev KK IDrugs; 2006 Apr; 9(4):279-82. PubMed ID: 16596482 [TBL] [Abstract][Full Text] [Related]
9. RNAi medicine for the brain: progresses and challenges. Boudreau RL; Rodríguez-Lebrón E; Davidson BL Hum Mol Genet; 2011 Apr; 20(R1):R21-7. PubMed ID: 21459775 [TBL] [Abstract][Full Text] [Related]
10. [RNA interference: biology and perspectives of application in biomedicine and biotechnology]. Vil'gel'm AE; Chumakov SP; Prasolov VS Mol Biol (Mosk); 2006; 40(3):387-403. PubMed ID: 16813159 [TBL] [Abstract][Full Text] [Related]
11. RNAi: a novel antisense technology and its therapeutic potential. Dallas A; Vlassov AV Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063 [TBL] [Abstract][Full Text] [Related]
12. Delivering RNA interference to the mammalian brain. Fountaine TM; Wood MJ; Wade-Martins R Curr Gene Ther; 2005 Aug; 5(4):399-410. PubMed ID: 16101514 [TBL] [Abstract][Full Text] [Related]
13. Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy. Guzman-Aranguez A; Loma P; Pintor J Br J Pharmacol; 2013 Oct; 170(4):730-47. PubMed ID: 23937539 [TBL] [Abstract][Full Text] [Related]
14. Illuminating the gateway of gene silencing: perspective of RNA interference technology in clinical therapeutics. Sindhu A; Arora P; Chaudhury A Mol Biotechnol; 2012 Jul; 51(3):289-302. PubMed ID: 21947958 [TBL] [Abstract][Full Text] [Related]
15. The silent treatment: RNAi as a defense against virus infection in mammals. van Rij RP; Andino R Trends Biotechnol; 2006 Apr; 24(4):186-93. PubMed ID: 16503061 [TBL] [Abstract][Full Text] [Related]
16. [Therapeutic RNA interference for neurodegenerative diseases]. González-Alegre P Rev Neurol; 2008 Dec 16-31; 47(12):641-7. PubMed ID: 19085881 [TBL] [Abstract][Full Text] [Related]
17. Antiviral RNAi therapy: emerging approaches for hitting a moving target. Leonard JN; Schaffer DV Gene Ther; 2006 Mar; 13(6):532-40. PubMed ID: 16177819 [TBL] [Abstract][Full Text] [Related]
18. RNAi therapy for neurodegenerative diseases. Boudreau RL; Davidson BL Curr Top Dev Biol; 2006; 75():73-92. PubMed ID: 16984810 [TBL] [Abstract][Full Text] [Related]
19. RNA interference-based therapy and its delivery systems. Chen X; Mangala LS; Rodriguez-Aguayo C; Kong X; Lopez-Berestein G; Sood AK Cancer Metastasis Rev; 2018 Mar; 37(1):107-124. PubMed ID: 29243000 [TBL] [Abstract][Full Text] [Related]
20. siRNA as a route to new cancer therapies. Ameyar-Zazoua M; Guasconi V; Ait-Si-Ali S Expert Opin Biol Ther; 2005 Feb; 5(2):221-4. PubMed ID: 15757383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]